Arcus Biosciences to Present New Data from Phase 2 Studies of … – The Bakersfield Californian

HAYWARD, Calif.–(BUSINESS WIRE)–Apr 24, 2024–. Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused …

Do you trust this headline?

Based on recent headline ratings, 60% of this readership currently trusts the local media, which has an average score of 84% regionally and is currently trending negative.


Media Trust Score60%